tel: (+98) 21 88885513 | info@viralian.com
VESTEND is the brand name of solifenacin succinate tablets produced by Viralian Company, available in 5 mg and 10 mg doses. This drug belongs to the group of antimuscarinics and works by blocking M3 muscarinic receptors in the bladder muscle, thereby reducing involuntary bladder contractions and increasing bladder capacity.
VESTEND is prescribed to treat symptoms of overactive bladder such as urinary frequency, urgency, and incontinence in adults. The usual starting dose is 5 mg once daily, which can be increased to 10 mg based on patient response and tolerance. The medication should be taken regularly as directed by a physician.
VESTEND should be avoided in patients with urinary retention, uncontrolled narrow-angle glaucoma, or severe liver impairment. Common side effects include dry mouth, constipation, and blurred vision, which are generally mild and temporary.
VESTEND tablets, manufactured by Viralian Company with high quality and in accordance with international pharmaceutical standards, provide an effective and safe option for managing bothersome symptoms of overactive bladder.